News
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...
Before approving Covid vaccines for wider use ... given the absence of new evidence to suggest concerns about the effectiveness or side effects. It “does seems to be based more on this ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results